Mescaline enhances emotional empathy via 5-HT 2A receptor activation

Background: Classic psychedelics are being re-investigated as treatments for psychiatric disorders. Deficits in social cognition and empathy are associated with various neuropsychiatric conditions and impaired mental health. Recent studies indicate that lysergic acid diethylamide and psilocybin may affect emotional processing and empathy, but acute effects of mescaline, another classic serotonergic psychedelic, have not yet been studied. Aims: To assess the acute effects of different mescaline doses on empathy and plasma oxytocin, and to determine the role of serotonin 5-hydroxytryptamine-2A (5-HT 2A ) receptor activation in mediating these effects. Methods: In a placebo-controlled, double-blind, random-order crossover study (NCT04849013), 16 healthy participants (aged 25–55 years, 8 women) received placebo, mescaline (100, 200, 400, and 800 mg), and 800 mg mescaline plus 40 mg ketanserin (5-HT 2A receptor antagonist). Cognitive and emotional empathy were assessed with the Multifaceted Empathy Test (MET) at 6 hours. Subjective empathogenic effects were repeatedly rated on visual analog scales, and plasma oxytocin concentrations were measured up to 30 hours after drug administration. Results: Mescaline induced dose-dependent subjective feelings of happiness and trust. On the MET, mescaline significantly enhanced emotional empathy in a dose-dependent manner but reduced cognitive empathy. Plasma oxytocin concentrations increased dose-dependently but were significantly elevated only after 400 and 800 mg mescaline compared with placebo. Co-administration of ketanserin blocked the mescaline-induced effects on empathy and oxytocin release. Conclusions: These results provide further evidence that classic psychedelics acutely alter empathy and plasma oxytocin concentrations by interacting with 5-HT 2A receptors.

Authors

Institutions

Publication Details

Journal
Journal of Psychopharmacology
Published
2026-11-19
DOI
https://doi.org/10.1177/02698811261504423
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mescaline enhances emotional empathy via 5-HT 2A receptor activation

Nimmy Varghese, Aaron Klaiber, Patrick Vizeli, Yasmin Schmid et al.
Journal of Psychopharmacology
Psychedelics and Drug Studies
article

Mescaline enhances emotional empathy via 5-HT 2A receptor activation

Nimmy Varghese, Aaron Klaiber, Patrick Vizeli, Yasmin Schmid, Anne Eckert, Matthias E. Liechti
article en

Abstract

Background: Classic psychedelics are being re-investigated as treatments for psychiatric disorders. Deficits in social cognition and empathy are associated with various neuropsychiatric conditions and impaired mental health. Recent studies indicate that lysergic acid diethylamide and psilocybin may affect emotional processing and empathy, but acute effects of mescaline, another classic serotonergic psychedelic, have not yet been studied. Aims: To assess the acute effects of different mescaline doses on empathy and plasma oxytocin, and to determine the role of serotonin 5-hydroxytryptamine-2A (5-HT 2A ) receptor activation in mediating these effects. Methods: In a placebo-controlled, double-blind, random-order crossover study (NCT04849013), 16 healthy participants (aged 25–55 years, 8 women) received placebo, mescaline (100, 200, 400, and 800 mg), and 800 mg mescaline plus 40 mg ketanserin (5-HT 2A receptor antagonist). Cognitive and emotional empathy were assessed with the Multifaceted Empathy Test (MET) at 6 hours. Subjective empathogenic effects were repeatedly rated on visual analog scales, and plasma oxytocin concentrations were measured up to 30 hours after drug administration. Results: Mescaline induced dose-dependent subjective feelings of happiness and trust. On the MET, mescaline significantly enhanced emotional empathy in a dose-dependent manner but reduced cognitive empathy. Plasma oxytocin concentrations increased dose-dependently but were significantly elevated only after 400 and 800 mg mescaline compared with placebo. Co-administration of ketanserin blocked the mescaline-induced effects on empathy and oxytocin release. Conclusions: These results provide further evidence that classic psychedelics acutely alter empathy and plasma oxytocin concentrations by interacting with 5-HT 2A receptors.

Journal of Psychopharmacology
University of Basel (CH), University Hospital of Basel (CH)
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon